Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy

Journal of the American Chemical Society - Tập 142 Số 10 - Trang 4944-4954 - 2020
Haijie Han1,2, Yi Hou3, Xiaohong Chen2, Peisen Zhang3, Muxing Kang4, Qiao Jin2, Jian Ji2, Mingyuan Gao3,5
1Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, P. R. China
2MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China
3Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Bei Yi Jie 2, Zhong Guan Cun, Beijing 100190, P. R. China
4Department of Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, P. R. China
5State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, School for Radiological and Interdisciplinary Sciences, Soochow University, Suzhou 215123, P. R. China

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1038/nrdp.2016.22

10.3322/caac.21387

10.1093/annonc/mdq545

10.1021/mp300370t

10.1021/acsnano.6b05541

10.1038/nnano.2007.387

10.1021/acsnano.5b07781

10.1021/ja312004m

10.1021/acsnano.5b00510

10.1038/nrgastro.2012.115

10.1016/j.canlet.2016.12.035

10.1136/gutjnl-2018-316451

10.1016/j.addr.2018.06.014

10.1021/acsnano.7b01026

10.1073/pnas.1318415110

10.1016/j.canlet.2015.09.007

10.1021/acsnano.7b02918

10.1002/smll.201900631

10.1021/acs.nanolett.9b00374

10.1021/acsnano.5b00510

10.1038/s41467-018-05906-x

10.1021/jacs.9b10755

10.1021/jacs.8b13507

10.1002/anie.201814730

10.1002/anie.201800511

10.1021/acsnano.7b01522

10.1016/j.cell.2014.08.007

10.1073/pnas.1117610109

10.1021/nn404083m

10.1016/j.cell.2016.11.055

10.1038/nature13110

10.1021/acs.molpharmaceut.5b00577

10.1038/bjc.2016.385

10.1038/nm.3787

10.1038/bjc.2013.187

10.1038/cddis.2012.13

10.1016/j.canlet.2016.10.019

10.1042/CS20090293

10.1016/j.abb.2014.11.002

10.1021/acsnano.8b07746

10.1021/acssensors.6b00396

10.1021/ja2081263

10.1002/jcp.22824

10.1096/fj.03-1273rev

10.1016/j.canlet.2017.01.041

10.1136/gutjnl-2015-309304

10.1016/j.addr.2015.10.022

10.1016/j.addr.2017.04.003

10.1016/j.addr.2017.06.003

10.1002/adma.201701095

10.1021/jacs.7b08900

10.1021/nn3043463

10.1007/s12029-013-9561-z

10.1016/j.ccr.2012.01.007

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma, https://clinicaltrials.gov/ct2/show/NCT02715804?term=halozyme+301&rank=1.

10.1158/2159-8290.CD-11-0242

10.1056/NEJMoa1304369

10.1038/s41586-019-1005-x

10.1038/s41467-017-02733-4

10.1038/s41591-018-0087-6

10.1038/s41467-019-10839-0

10.1038/s41388-019-0942-z